No abstract

No abstract

Background: pain after a caesarean section is still a problem. Evaluation of the pain intensity needs selection a suitable anesthetic method, medication, and dosage, as well as the enhancement of postoperative pain therapy. Aim of the work:To assess the successful of an ultrasound-guided transversus abdominis plane block following a caesarian operation regarding patient safety, pain treating, and satisfaction. Patients and methods: Prospective observational research trial, whereas 200 of Gravid women shared and equally distributed to double collections, each collection includes 100 of women: first got TAP block and the other did not get TAP block. After the abdominal delivery, with evaluation of the pain intensity. Results:The pain score, the requirement for extra rescue analgesia, and some minor problems were examined 2, 4, 8, 12, and 24 hours after procedure. In all time periods, the degree of discomfort in "group A" was considerably less than in "group B" (p >0.001). Only 42% of women in "group A" required further rescue analgesia, while 100% of women in "group B" did. Early on, at 2 hours post-operatively, nausea and vomiting were greater in women in "group B" compared to those in "group A," with a p-value of 0.037*. Intestinal motility was audible sooner in "group A" than in "group B," and the same was true for mobilization time and breast feeding, which were both earlier in "group A.". Conclusion: Ultrasound guided TAP block showed an efficacy in controlling pain after cesarean section providing an effective and safe postoperative analgesia.

Background: This condition is known as preeclampsia, which is characterized by new-onset hypertension after twenty weeks of gestation with indications of organ damage; the potential maternal and neonatal consequences of preeclampsia are considerable. Aim of the work: The study's goal is to determine the function and efficiency of low molecular weight heparin in avoiding severe preeclampsia. Patients and methods:The study is randomized, interventional study and carried out on cases of high risk of pre-eclampsia at obstetrics, gynecology department al-azhar university hospitals. Our study was done on one hundred participants of high risk of pre-eclampsia separate into 2 groups; Group 1 (study group): in accordance with standard regimen, 50 patients got low molecular weight heparin. Group 2 (control group): contain 50 cases had received usual regimen only. Results:The current results show statistically significant differences between groups according to patient's clinical improvement, APGAR score and NICU admission with more improvement in patients who received low molecular weight heparin in accordance with usual regimen when it compared to other group which contain cases received usual regimen only (control group). Conclusion: low molecular weight heparin is effective in preventing development of severe preeclampsia in patients with mild preeclampsia on expectant management of this resulting in less maternal, fetal and neonatal morbidity and mortality.

No abstract